Siemens Healthineers

Dipping in 2020

30/12/19 -"We have re-worked our financial model after some initial adjustments. Our general view on the company remains broadly unchanged, but the incorporation of the AR's full set of figures and a stronger ..."

Published on
You may also be interested by these reports :
Sales missed expectations in Q3 due to the delay in installations of linacs in the US. Order intake was also weak with the US being the main drag. ...

Smith & Nephew reported good Q4/FY 19 numbers – trumping estimates. Q4/FY 19 sales were up 5.6%/4.4% on an underlying basis – driven by broad-based ...

We have not become more enthusiastic, but the inclusion of FMC’s better than expected performance has caused the increase in the EPS. The moderate ...

We have not become more enthusiastic, but the inclusion of the preliminary figures has caused the increase in the EPS. However, the quite colourless ...


Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis


AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO